CA1028699A - Derives de l'acide prostanoique - Google Patents

Derives de l'acide prostanoique

Info

Publication number
CA1028699A
CA1028699A CA198,097A CA198097A CA1028699A CA 1028699 A CA1028699 A CA 1028699A CA 198097 A CA198097 A CA 198097A CA 1028699 A CA1028699 A CA 1028699A
Authority
CA
Canada
Prior art keywords
acid derivatives
prostanoic acid
prostanoic
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA198,097A
Other languages
English (en)
Other versions
CA198097S (en
Inventor
Mitsuo Yamazaki
Masaaki Sasaki
Takashi Yusa
Kiyoshi Sakai
Osamu Oda
Kazuhiko Sasagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of CA1028699A publication Critical patent/CA1028699A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
CA198,097A 1973-04-19 1974-04-25 Derives de l'acide prostanoique Expired CA1028699A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4444473A JPS5623984B2 (fr) 1973-04-19 1973-04-19

Publications (1)

Publication Number Publication Date
CA1028699A true CA1028699A (fr) 1978-03-28

Family

ID=12691648

Family Applications (1)

Application Number Title Priority Date Filing Date
CA198,097A Expired CA1028699A (fr) 1973-04-19 1974-04-25 Derives de l'acide prostanoique

Country Status (10)

Country Link
US (1) US4012429A (fr)
JP (1) JPS5623984B2 (fr)
BE (1) BE813988A (fr)
CA (1) CA1028699A (fr)
CH (1) CH590835A5 (fr)
DE (1) DE2419025A1 (fr)
FR (1) FR2226182B1 (fr)
GB (1) GB1431414A (fr)
NL (1) NL7405374A (fr)
SE (1) SE7405215L (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931282A (en) * 1974-02-21 1976-01-06 Syntex (U.S.A.) Inc. 11α-Hydroxymethyl prostaglandins
JPS51128941A (en) * 1975-02-27 1976-11-10 Sagami Chem Res Center Process for preparing 2,3-disubstituted cyclopentanone derivatives
JPS51110536A (ja) * 1975-02-27 1976-09-30 Sagami Chem Res Shikuropentanonjudotaino seizohoho
JPS51100044A (en) * 1975-02-27 1976-09-03 Sagami Chem Res 2 33 jichikanshikuropentanonjudotaino seizoho
DE2557335A1 (de) * 1975-12-19 1977-07-07 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
DE2557748A1 (de) * 1975-12-20 1977-06-30 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
US4217284A (en) * 1976-10-05 1980-08-12 Kowa Company Ltd. Process for preparation of optically pure lactones from monoesters of cis-cyclopentenediol
CA2705150C (fr) * 2007-11-09 2016-06-14 Allergan, Inc. Cyclopentanes substitues ayant une activite de prostaglandine
US8299068B2 (en) * 2010-01-29 2012-10-30 Allergan, Inc. Therapeutically active cyclopentanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (fr) * 1970-06-10 1975-02-04
US3849474A (en) * 1972-03-27 1974-11-19 Ayerst Mckenna & Harrison 11-deoxyprostaglandin derivatives and process therefor
US3845042A (en) * 1972-08-21 1974-10-29 American Home Prod 11-substituted-prostaglandin derivatives
GB1436378A (en) * 1972-08-21 1976-05-19 American Home Prod Prostaglandin derivatives
US3931282A (en) * 1974-02-21 1976-01-06 Syntex (U.S.A.) Inc. 11α-Hydroxymethyl prostaglandins

Also Published As

Publication number Publication date
FR2226182A1 (fr) 1974-11-15
NL7405374A (fr) 1974-10-22
JPS5623984B2 (fr) 1981-06-03
GB1431414A (en) 1976-04-07
BE813988A (fr) 1974-10-21
US4012429A (en) 1977-03-15
CH590835A5 (fr) 1977-08-31
FR2226182B1 (fr) 1978-07-21
SE7405215L (fr) 1974-12-11
JPS49127953A (fr) 1974-12-07
DE2419025A1 (de) 1974-11-07

Similar Documents

Publication Publication Date Title
ZM12074A1 (en) Prostanoic acid derivatives
CA1027558A (fr) Derives de l'acide mycophenolique
CA969549A (en) 2-anilino-nicotinic acid derivatives
CA1034118A (fr) Derives d'acide oxamique
CA1028699A (fr) Derives de l'acide prostanoique
CA1014564A (en) Derivatives of 1,3-benzodioxole-2-carboxylic acid
AU499409B2 (en) Cephalasporanic acid derivatives
CA1034577A (fr) Derives d'acide thienopyridine-carboxylique
CA1014549A (en) Methyleneaminopenicillanic acid derivatives
AU482077B2 (en) Prostanoic acid derivatives
CA1033728A (fr) Derives de l'acide prostanoique utiles en pharmacologie
IL44113A0 (en) Prostanoic acid derivatives
AU486645B2 (en) Imidazolyl-alkanoic acid derivatives
AU486111B2 (en) 4-phenyl-5-sulphamylmenzoic acid derivatives
AU481738B2 (en) Benzoyl-benzoic acid derivatives
AU480065B2 (en) Benzoyl-phenylacetic acid derivatives
CA1013749A (fr) Composes 2-alkoxy-4-phthalimido-5-acide halobenzoique
AU7036574A (en) Benzoyl-benzoic acid derivatives
AU7003474A (en) Benzoyl-phenylacetic acid derivatives
AU7052374A (en) Imidazolyl-alkanoic acid derivatives
AU7292374A (en) 4-phenyl-5-sulphamylmenzoic acid derivatives
ZA74469B (en) Prostanoic acid derivatives
CA903767A (en) Prostanoic acid derivatives
AU482145B2 (en) Prostanoic acid derivatives
AU481170B2 (en) Prostanoic acid derivatives